Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05033990 · ClinicalTrials.gov registry record
SPIROMICS Study of Early COPD Progression (SOURCE)
A clinical trial of COPD, Early-Onset, sponsored by University of Massachusetts, Worcester.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 14
- Study locations
NCT05033990 is a study of COPD, Early-Onset that is actively recruiting participants, run by University of Massachusetts, Worcester. The registered enrollment target is 1,000 participants. The trial reports 14 study locations across 12 states.
The verdict
NCT05033990, a study of COPD, Early-Onset, is actively recruiting participants, sponsored by University of Massachusetts, Worcester.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 14
- Study locations
Study Summary
This is an observational study of 1000 participants to further define the nature of early chronic obstructive pulmonary disease (COPD) in younger, at-risk individuals. The study has three main goals: * To use CT scan imaging to identify which smokers will develop COPD. * To identify biomarkers predictive of smokers that will develop COPD. * To determine if sputum (phlegm) can be analyzed to predict which smokers will develop COPD. Procedures (methods): All participants will undergo study related questionnaires assessing medical history, smoke exposure and use, medication use, social and behavioral health, pulmonary symptoms, food frequency, and will provide nasal swab, blood, stool, and urine samples, pulmonary function testing to determine function, sputum induction to provide a sputum sample for airway biospecimen analysis, and CT imaging of the lungs.
Conditions Studied
Study Locations (14)
California
- University of California Los Angeles - Los Angeles
- University of California, San Francisco - San Francisco
New York
- Columbia University - New York
- Weill Cornell Medical Center - New York
Alabama
- University of Alabama at Birmingham - Birmingham
Arizona
- Mayo Clinic Arizona - Scottsdale
Colorado
- National Jewish Health - Denver
Illinois
- University of Illinois Chicago - Chicago
Iowa
- University of Iowa - Iowa City
Maryland
- Johns Hopkins Bayview Medical Center - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2021-09-08 |
| Est. Completion | 2026-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05033990
The ClinicalTrials.gov registry entry for NCT05033990 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with COPD, Early-Onset appearing as the primary indexed condition, and to 0 interventions.
NCT05033990 reports 14 study locations spanning 12 distinct geographic areas - top geographies include California, New York, Alabama.
Frequently Asked Questions
What is clinical trial NCT05033990 about?
NCT05033990 is a clinical study titled "SPIROMICS Study of Early COPD Progression (SOURCE)". This is an observational study of 1000 participants to further define the nature of early chronic obstructive pulmonary disease (COPD) in younger, at-risk individuals. The study has three main goals: * To use CT scan imaging to identify which smokers will develop COPD. * To identify biomarkers pre...
What is the current status of trial NCT05033990?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2021-09-08. Estimated completion is 2026-04.
What conditions does trial NCT05033990 study?
This clinical trial studies the following conditions: COPD, Early-Onset.
Who is sponsoring clinical trial NCT05033990?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05033990 being conducted?
This trial has 14 study locations across Alabama, Arizona, California, Colorado, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.